6:04 PM
 | 
Nov 09, 2007
 |  BC Extra  |  Clinical News

Biogen Idec reports baminercept data

BIIB said interim data showed that baminercept (LTBR-Fc) plus methotrexate improved ACR measures in a Phase IIa trial in 47 patients with moderate to severe rheumatoid arthritis (RA)...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >